CIK 0001582554 · Non-accelerated filer<br>Smaller reporting company
Matinas BioPharma Holdings, Inc.
Sign in to watch- Ticker
- MTNB
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 463011414
- Phone
- 908-484-8805
- Business address
- 1545 ROUTE 206 SOUTH, SUITE 302, BEDMINSTER, NJ, 07921
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Gift Director gave 2,639,039 shares (gift)
- 8-K Event Regulation FD disclosure
- 4 Open-market buy Director bought 100,000 shares at $0.73 ($73,050)
- 4 Gift Director gave 2,639,039 shares (gift)
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 4 Option exercise Director acquired 278,407 shares (option exercise)
- 4 Grant or award Director acquired 26,450 shares (grant or award)
- S-8 Other Securities Offered to Employees in Benefit Plans
- 4 Open-market buy Director bought 10,000 shares at $0.65 ($6,500)
- 4 Open-market buy President and CEO bought 10,000 shares at $0.65 ($6,500)
- 8-K Event Results of operations
- 10-K Report Annual Report
- 8-K Event Agreement ended
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 424B5 Offering Prospectus
Page 15 of 29 · 576 filings